Project

HIGH DOSE IV METHYLCOBALAMIN FOR COVID 19 ACUTE RESPIRATORY DISTRESS SYNDROME

Updates
0 new
0
Recommendations
0 new
0
Followers
0 new
0
Reads
0 new
120

Project log

Carmen Wheatley
added a research item
High dose parenteral Cobalamin as prophylaxis and treatment for Covid19 and Sepsis/ARDS. This is a pop article, not a paper.
Carmen Wheatley
added a research item
A SAFE AND EFFICACIOUS PROPHYLACTIC /TREATMENT FOR COVID19, TO PREVENT AND TREAT ACUTE RESPIRATORY DISTRESS SYNDROME, ALREADY EXISTS: RESPECTIVELY using HIGH DOSE IM AND IV METHYLCOBALAMIN FORM OF VITAMIN B12. The hydroxocobalamin form of B12 has been used in ICUs in France, Italy and China for nearly 70 years, as the anti-CN antidote of choice. It is safe, licensed and available. Methylcobalamin would be preferable, for a number of research based reasons. But both could be life savers in the current health crisis.
Carmen Wheatley
added a research item
Corona Virus/ Covid19/ SARS-2-Covid has ground the world to a halt and is showing up the deficiencies of our health care systems everywhere, and the vulnerability of the global population. When Covid/19 kills, it kills through Acute Respiratory Distress Syndrome/ ARDS which, in effect, kills by a sepsis related process. Thus ARDS is fuelled by the proverbial "cytokine storm". It is also known that people who die of Covid 19 ARDS have a depletion of Natural Killer/NK cells, and poor immune function in general. Whether the virus depletes NK c e l l s , o r w h e t h e r t h o s e w h o a r e i m m u n o-compromised/elderly lack normal NK cell levels and activity is not known for sure. At this point in time, when the FDA have suddenly relaxed many drug control regulations, in order to be able to use off-label drugs in a desperate attempt to mitigate disaster, the FDA actually already have one powerful item in the armoury, to which, because of its safety and cost-effectiveness, combined